loadpatents
Patent applications and USPTO patent grants for Modi; Dilip P..The latest application filed is for "sustained release dosage forms for a jak1 inhibitor".
Patent | Date |
---|---|
Sustained Release Dosage Forms For A Jak1 Inhibitor App 20220016036 - Yeleswaram; Krishnaswamy ;   et al. | 2022-01-20 |
Sustained release dosage forms for a JAK1 inhibitor Grant 11,045,421 - Yeleswaram , et al. June 29, 2 | 2021-06-29 |
Sustained Release Dosage Forms For A Jak1 Inhibitor App 20200253879 - Kind Code | 2020-08-13 |
Sustained release dosage forms for a JAK1 inhibitor Grant 10,561,616 - Yeleswaram , et al. Feb | 2020-02-18 |
Sustained Release Dosage Forms For A Jak1 Inhibitor App 20170319487 - Yeleswaram; Krishnaswamy ;   et al. | 2017-11-09 |
Sustained release dosage forms for a JAK1 inhibitor Grant 9,655,854 - Yeleswaram , et al. May 23, 2 | 2017-05-23 |
Sustained Release Dosage Forms For A Jak1 Inhibitor App 20150065484 - Yeleswaram; Krishnaswamy ;   et al. | 2015-03-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.